Cancer Genome Atlas Reveals Similarities Between Certain Breast and Ovarian Cancers
USPSTF Delivers “D” Recommendation For Ovarian Cancer Screening
Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival
Immunotherapy Demonstrates Disease Control in Phase II Study
Finasteride Does Not Affect Quality of Life, Says Study
Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years
Study: Lack of Sleep Linked With Agressive Breast Cancers
HPV Can Affect Response To Radiation Therapies
Researchers Find 16 Gene Variants Linked to Colorectal Cancer Using CRCgene Database
NCI-Approved CTEP Trials For the Month of September
FDA Approves Imaging Agent For Recurrent Prostate Cancer
Trending Stories
- Columbia’s cancer center becomes collateral damage in Trump’s war on antisemitism
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Caught in the crossfire: The critical threats facing cancer centers, research, and patient care
- Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated